SBFM
Sunshine Biopharma, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$1.14
+2.70%Margins
Gross margin
29.8%
EBITDA margin
-14.9%
EBIT margin
-14.7%
Net margin
-16.5%
FCF margin
-13.0%
-21.2%
Return on equity
-17.3%
Return on assets
-18.4%
Return on invested capital
1.15x
Asset turnover
-$5.3M
Cash from operations
$3.55
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026